ENDRA Life Sciences
NDRA
2 hedge funds and large institutions have $4.65K invested in ENDRA Life Sciences in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
546% more capital invested
Capital invested by funds: $720 → $4.65K (+$3.93K)
0.19% more ownership
Funds ownership: 0.02% → 0.21% (+0.19%)
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$595 |
| 2 |
Morgan Stanley
New York
|
-$81 |
| 3 |
DB
Danske Bank
Copenhagen K,
Denmark
|
-$19 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $4.63K | +$5.47K | +1,130 | New |
|
2
Bank of America
Charlotte,
North Carolina
| $16 | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$595 | -95 | Closed |
|
|
4
Morgan Stanley
New York
| – | -$81 | -13 | Closed |
|
|
DB
5
Danske Bank
Copenhagen K,
Denmark
| – | -$19 | -3 | Closed |
|
NDRA Hedge Fund Activity: Q1 2025 in Review
2 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2025, worth a combined $4.65K — up 546% from $720 a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NDRA and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $5.47K. The largest seller was UBS Group, exiting entirely with an estimated $595 sold.
- 2 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2025, down from 4 in Q4 2024.
- Funds reported $4.65K of ENDRA Life Sciences stock for Q1 2025, up 546% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q1 2025 and 3 closed out, a net change of -2 holders.
- The largest ENDRA Life Sciences buyer in Q1 2025 was Tower Research Capital (TRC), an estimated $5.47K added.
- The largest ENDRA Life Sciences seller in Q1 2025 was UBS Group, an estimated $595 sold.
Based on aggregated 13F filings for Q1 2025.